Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_3
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
2(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Enrolling by invitation1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 32 (100.0%)

Trials by Status

enrolling_by_invitation133%
unknown133%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_3

Berotralstat Treatment in Children With Hereditary Angioedema

NCT05453968
enrolling_by_invitationphase_3

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

NCT04933721
unknown

Oral Berotralstat Expanded Access Program

NCT04428632

Clinical Trials (3)

Showing 3 of 3 trials
NCT05453968Phase 3

Berotralstat Treatment in Children With Hereditary Angioedema

Active Not Recruiting
NCT04933721Phase 3

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

Enrolling By Invitation
NCT04428632

Oral Berotralstat Expanded Access Program

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3